These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35210049)

  • 21. Revascularization Deferral of Nonculprit Stenoses on the Basis of Fractional Flow Reserve: 1-Year Outcomes of 8,579 Patients.
    Cerrato E; Mejía-Rentería H; Dehbi HM; Ahn JM; Cook C; Dupouy P; Baptista SB; Raposo L; Van Belle E; Götberg M; Davies JE; Park SJ; Escaned J
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1894-1903. PubMed ID: 32739305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision.
    Lee JM; Kim H; Hong D; Hwang D; Zhang J; Hu X; Jiang J; Nam CW; Doh JH; Lee BK; Kim W; Huang J; Jiang F; Zhou H; Chen P; Tang L; Jiang W; Chen X; He W; Kang J; Ahn SG; Yoon MH; Kim U; Ki YJ; Shin ES; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Koo BK; Kim HS; Tahk SJ; Wang J; Hahn JY;
    Circ Cardiovasc Interv; 2023 Dec; 16(12):e013308. PubMed ID: 38018840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deferral Versus Performance of Revascularization for Coronary Stenosis With Grey Zone Fractional Flow Reserve Values: A Systematic Review and Meta-Analysis.
    Du Y; Liu Y; Cai G; Yang B; Cheng Y; Liu J; Liu W; Liu X; Zhou Z; Zhao Y; Zhou Y
    Angiology; 2020 Jan; 71(1):48-55. PubMed ID: 31315429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.
    Li SJ; Ge Z; Kan J; Zhang JJ; Ye F; Kwan TW; Santoso T; Yang S; Sheiban I; Qian XS; Tian NL; Rab TS; Tao L; Chen SL
    JACC Cardiovasc Interv; 2017 May; 10(10):986-995. PubMed ID: 28456699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Outcomes According to Fractional Flow Reserve or Instantaneous Wave-Free Ratio in Deferred Lesions.
    Lee JM; Shin ES; Nam CW; Doh JH; Hwang D; Park J; Kim KJ; Zhang J; Ahn C; Koo BK
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2502-2510. PubMed ID: 29198458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
    Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Treatment Strategy for Coronary Artery Stenoses with Grey Zone Fractional Flow Reserve Values. A Systematic Review and Meta-Analysis.
    Andreou C; Zimmermann FM; Tonino PAL; Maniotis C; Koutouzis M; Poulimenos LE; Triantafyllis AS
    Cardiovasc Revasc Med; 2020 Mar; 21(3):392-397. PubMed ID: 31227391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome.
    Masrani Mehta S; Depta JP; Novak E; Patel JS; Patel Y; Raymer D; Facey G; Zajarias A; Lasala JM; Singh J; Bach RG; Kurz HI
    J Am Heart Assoc; 2015 Aug; 4(8):e002172. PubMed ID: 26289346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial.
    Piroth Z; Otsuki H; Zimmermann FM; Ferenci T; Keulards DCJ; Yeung AC; Pijls NHJ; De Bruyne B; Fearon WF
    Circ Cardiovasc Interv; 2022 Nov; 15(11):884-891. PubMed ID: 36121706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure.
    Uretsky BF; Agarwal SK; Vallurupalli S; Al-Hawwas M; Miller K; Biscaglia S; Hakeem A
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2192-2202. PubMed ID: 36357023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    McInerney A; Travieso Gonzalez A; Castro Mejía A; Tirado-Conte G; Mejía-Rentería H; Cerrato E; Nombela-Franco L; Jiménez-Quevedo P; Salinas P; Macaya Ten F; Núñez Gil I; Fernandez Ortiz A; Macaya C; Escaned J; Gonzalo N
    Catheter Cardiovasc Interv; 2022 Feb; 99(3):723-729. PubMed ID: 34156742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal Revascularization Threshold of Fractional Flow Reserve and its Effect on Outcomes: Perspectives From a High-Volume Center in China.
    Du Y; Yang B; Zhang J; Liu W; Wang Z; Ji Q; Ma X; Han H; Guo Y; Liu X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):423-430. PubMed ID: 30343583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    ; Lee JM; Choi KH; Koo BK; Dehbi HM; Doh JH; Nam CW; Shin ES; Cook CM; Al-Lamee R; Petraco R; Sen S; Malik IS; Nijjer SS; Mejía-Rentería H; Alegria-Barrero E; Alghamdi A; Altman J; Baptista SB; Bhindi R; Bojara W; Brugaletta S; Silva PC; Di Mario C; Erglis A; Gerber RT; Going O; Härle T; Hellig F; Indolfi C; Janssens L; Jeremias A; Kharbanda RK; Khashaba A; Kikuta Y; Krackhardt F; Laine M; Lehman SJ; Matsuo H; Meuwissen M; Niccoli G; Piek JJ; Ribichini F; Samady H; Sapontis J; Seto AH; Sezer M; Sharp ASP; Singh J; Takashima H; Talwar S; Tanaka N; Tang K; Van Belle E; van Royen N; Vinhas H; Vrints CJ; Walters D; Yokoi H; Samuels B; Buller C; Patel MR; Serruys P; Escaned J; Davies JE
    JAMA Cardiol; 2019 Sep; 4(9):857-864. PubMed ID: 31314045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-randomized comparison between revascularization and deferral for intermediate coronary stenosis with abnormal fractional flow reserve and preserved coronary flow reserve.
    Shin D; Lee JM; Lee SH; Hwang D; Choi KH; Kim HK; Doh JH; Nam CW; Shin ES; Hoshino M; Murai T; Yonetsu T; Mejía-Rentería H; Kakuta T; Escaned J; Koo BK
    Sci Rep; 2021 Apr; 11(1):9126. PubMed ID: 33911143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry.
    Van Belle E; Rioufol G; Pouillot C; Cuisset T; Bougrini K; Teiger E; Champagne S; Belle L; Barreau D; Hanssen M; Besnard C; Dauphin R; Dallongeville J; El Hahi Y; Sideris G; Bretelle C; Lhoest N; Barnay P; Leborgne L; Dupouy P;
    Circulation; 2014 Jan; 129(2):173-85. PubMed ID: 24255062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients With Stent Implantation.
    Shin D; Lee SH; Lee JM; Choi KH; Hwang D; Lee HJ; Jang HJ; Kim HK; Kwak JJ; Ha SJ; Song YB; Shin ES; Doh JH
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1920-1933. PubMed ID: 32819481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values.
    Megaly M; Khalil C; Saad M; Xenogiannis I; Omer M; Anantha Narayanan M; Pershad A; Garcia S; Seto AH; Burke MN; Brilakis ES
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008315. PubMed ID: 31752518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of malondialdehyde-modified low-density lipoprotein on clinical outcomes after fractional flow reserve-guided deferral of revascularization.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Heart Vessels; 2021 May; 36(5):605-614. PubMed ID: 33219835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractional flow reserve in patients with reduced ejection fraction.
    Di Gioia G; De Bruyne B; Pellicano M; Bartunek J; Colaiori I; Fiordelisi A; Canciello G; Xaplanteris P; Fournier S; Katbeh A; Franco D; Kodeboina M; Morisco C; Van Praet F; Casselman F; Degrieck I; Stockman B; Vanderheyden M; Barbato E
    Eur Heart J; 2020 May; 41(17):1665-1672. PubMed ID: 31419282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.